Proxima
PrivateLast Round
Series B
Jun 10, 2026
Total Funding Raised
$80.33M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Proxima is a biotechnology company that provides an AI-driven drug discovery platform for proximity therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Proxima Comparables
Compare Proxima with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rezo Therapeutics | 82% | |
| Orionis Biosciences | 80% | |
| Insitro | 79% |
Proxima Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 10, 2026 | ||||
| Seed | Jan 13, 2026 | ||||
| Pre Seed | Oct 10, 2024 | ||||
| Grant | May 24, 2023 |
Key People
Founding team and executive leadership
Proxima Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Magnetic Ventures | Seed |
| Braidwell | Seed |
| Magnetic Ventures | Seed |
| NVentures | Seed |
| Yosemite | Seed |
| Alexandria Venture Investments | Seed |
| NVentures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 57% MoM, from 5.1K to 8K.
- Jun 10, 2026
$91M round completed.
Recent news
Latest coverage and updates
- is_developingJun 23, 2026
Proximabio is developing tools to accelerate therapeutic design workflows on Jun 23rd '26.
Proxima Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Proxima's valuation, stock price, and market status.
Is Proxima a public or private company?
Proxima is a private company.
What is the current stock price of Proxima?
Proxima is a private company with no public stock price. No recent secondary market data is available.
How much is Proxima worth (valuation)?
Valuation information for Proxima is not publicly available.
Can I buy Proxima stock?
Proxima shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Proxima's last funding round?
Proxima's most recent funding round was Series B on June 10, 2026.
Who are the main investors in Proxima?
Key investors in Proxima include DCVC (Data Collective).
Will Proxima IPO soon?
No public IPO plans have been announced for Proxima.
How can I track Proxima secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Proxima's secondary market activity and sign up for updates.